Skip to main content

Provider

By Jessica Hagen | 05:50 pm | August 08, 2023
The company will use the funds to grow its offerings, including its teletherapy platform, and expand its reach nationally.
By Jessica Hagen | 01:05 pm | August 08, 2023
Amazon employees in 50 countries outside the U.S. and Canada will have access to Maven Clinic's fertility and family-building services with local resources.
By HIMSS TV | 07:00 am | August 08, 2023
Dr Cátia Pinto, international affairs unit coordinator at SPMS in Portugal, discusses the country’s digital health infrastructure, its use of EU recovery and resilience funds and the creation of an international health data space.
By Jessica Hagen | 07:06 pm | August 07, 2023
The Tennessee-based company has regained compliance with the bid price requirement to remain listed on the NASDAQ.
By Jessica Hagen | 02:56 pm | August 07, 2023
The company also seeks to sell its U.K. business to third parties, exit the U.S. market and continue trying to sell Meritage Medical Network.
By HIMSS TV | 07:00 am | August 07, 2023
Dr. Brian Anderson, MITRE’s chief digital health physician and Coalition for Health AI cofounder, says AI requires regulation. He discusses the blueprint CHI developed for bias-mitigation, transparency, governance and monitoring in AI.
By Jessica Hagen | 04:09 pm | August 04, 2023
The company reported second-quarter revenue of $18.5 million with a net loss of $28.7 million, alongside operating expenses totaling $42.2 million.
By Jessica Hagen | 03:16 pm | August 03, 2023
Informa Markets will manage the massive health technology conference, while HIMSS will continue overseeing content and programming.
By HIMSS TV | 01:02 pm | August 03, 2023
Leaders from both organizations discuss the motivations behind and the goals of Informa Markets' deal to manage the HIMSS Global Health Conference and Exhibition.
By HIMSS TV | 11:20 am | August 03, 2023
Amir Bozorgzadeh, cofounder and CEO of Virtuleap, which combines neuroscience and virtual reality for brain training, discusses a partnership with Roche to screen for precursors of cognitive impairment.